Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsEventsSponsored PodcastsSponsored VideosWebcastsWhitepaperseBooks
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Maria Fe Paz

Advertisement

Articles by Maria Fe Paz

i2-808526-1408547104797.gif

Early Engagement with Medical Laboratories

ByPeter Keeling,Maria Fe Paz
March 1st 2013

Pharmaceutical Executive

Timely engagement is the key to expanding the use of companion diagnostics.

Advertisement

Latest Updated Articles

  • i2-808526-1408547104797.gif
    Early Engagement with Medical Laboratories

    March 1st 2013



Advertisement
Advertisement

Trending on PharmExec

1

Roundup: TRexBio & Retension Pharmaceuticals Announce IPO Pricing

2

FDA Approves Tecentriq for Stage III dMMR Colon Cancer

3

Viatris Acquires Pacira BioSciences for $1.65 Billion

4

The Most Important Lessons Learned from Building CGT Supply Chains: LogiPharma 2026

5

Ultragenyx to Sell Rare Pediatric Disease Priority Review Voucher for $210 Million

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us